New York, October 05, 2021 – Reports and Data has published its latest report titled “Nanomedicine Market” Analysis By Products (Therapeutics, Regenerative Medicine, In-vitro diagnostics, In-vivo diagnostic, Vaccines), By Drug Delivery System (Nanobots, Nanoghosts, Nanoclusters, Nanobubbles, Exosomes, Injectable Nanoparticle Generator, Dendrimers, Liposomes, Carbon nanotube, Graphene, Others), By Application (Oncology, Infectious diseases, Cardiology, Orthopedics, Others) And Segment Forecasts to 2028”.
Rising investments on R&D activities for development of novel therapies, growing incidence of cancer & genetic and cardiovascular diseases, and development of nanoscale technologies are some key factors driving market growth
Download sample @ https://www.reportsanddata.com/sample-enquiry-form/1048
According to Reports and Data, the global nanomedicine market size was USD 168.37 billion in 2020 and is expected register a revenue CAGR of 12.6% during the forecast period, 2021-2028.
Drivers, Restraints, and Opportunities
Nanomedicine is a discipline of medicine that employs nanotechnology’s knowledge and techniques to illness prevention and treatment. Nanomedicine involves the use of biocompatible nanoparticles and nanorobots and other nanoscale materials, for delivery, sensing, diagnosis, or actuation purposes in a living organism.
Ongoing R&D activities and private and government investments in the healthcare industry for the introduction of novel therapies to treat cancer is expected to positively impact revenue growth of the market over the forecast period. According to World Health Organization estimates, approximately 9.5 million people died of cancer in 2018, making it the world’s second largest cause of death. Nanomedicine has the potential to completely eradicate the disease, leading to increase in private investment in the nanomedicine market.
In addition, growing awareness regarding nanomedicine, prevalence of chronic and infectious diseases, abundance of research publications, application of AI to monitor infectious diseases and rise in healthcare expenditure are some other key factors contributing to the revenue growth of the market.
However, high medical cost and side-effects of nanomedicine treatments (such as cardiotoxicity, nephrotoxicity, deafness), are some major factor expected to restrain global nanomedicine market revenue growth over the forecast period.
COVID-19 Impact Analysis
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
To know more about the report @ https://www.reportsanddata.com/report-detail/nanomedicine-market
Therapeutics Type to Account for Largest Revenue Share:
Therapeutics segment is expected to account for largest revenue share in the global market over the forecast period attributed to rapidly advancing medical field of nanomedicine, surging clinical R&D investments along with the provision of reimbursements and government favorable policies.
Dendrimers Segment to Dominate Other Drug Delivery System Segment:
Dendrimers segment is expected to dominate other drug delivery system segment over the forecast period attributed to increase in nanomedicine research and development activities. Further, structural features, such as a well-defined globular form with controllable nanostructures and highly branched, make it the most effective drug delivery option for nanomedicine. This factor is expected to further drive revenue growth of this segment.
North America to Account for a Significantly Large Revenue Share:
North America is expected to account for a significantly large revenue share over the forecast period owing to increasing investments into the development of healthcare system including medical devices to improve efficacy and efficiency, and presence of key participants in the region.
Asia Pacific to Lead in Terms of Revenue CAGR:
Asia Pacific market revenue is expected to expand at a robust revenue CAGR over the forecast period attributed to growing incidence of cancer, rapid urbanization and rising adoption of novel nanomedicines products. In addition, private and government investments for availability of basic health technologies through insurance schemes especially in emerging economies namely India and China drive revenue growth of the APAC market.
Major Companies in the Market Include:
- Arrowhead Pharmaceuticals Inc.
- AMAG Pharmaceuticals
- Bio-Gate AG
- Celgene Corporation
- Johnson & Johnson Circassia
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1048
Market Segmentation:
For the purpose of this report, Reports and Data has segmented the global nanomedicine market on the product, drug delivery system, application, and region:
Product Outlook (Revenue, USD Billion; 2018-2028)
- Therapeutics
- Regenerative Medicine
- In-vitro diagnostics
- In-vivo diagnostic
- Vaccines
Drug Delivery System Outlook (Revenue, USD Billion; 2018-2028)
- Nanobots
- Nanoghosts
- Nanoclusters
- Nanobubbles
- Exosomes
- Injectable Nanoparticle Generator
- Dendrimers
- Liposomes
- Carbon nanotube
- Graphene
- Others
Application Outlook (Revenue, USD Billion; 2018-2028)
- Oncology
- Infectious diseases
- Cardiology
- Orthopedics
- Others
Buy Now Premium Research Report – https://www.reportsanddata.com/checkout-form/1048
Regional Outlook (Revenue, USD Billion; 2018-2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Sweden
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.E.A
- South Africa
- Israel
- Rest of MEA
Some points on how the report benefits stakeholders:
- The reports include historical (2018–2020) and forecast (2021–2028) data points, revenues, and CAGR in table, figure, and chart formats, with detailed and qualitative, supporting written information for each.
- Revenue break-up is provided for each segment in these formats for global, regional, and for each country in the respective region for each year between 2018 and 2028.
- The report contains insights regarding growth drivers, restraints, opportunities, trends, company profiles, strategic developments, expansion details, product launches, and various other aspects related to the market.
- The report contains data and information on customers, competitors, vendors/distributors, and other players and in the global marketplace.
- Market research analysis is vital for all crucial business strategies and can aid in numerous ways and to provide a clearer understanding about strategies being deployed by competitors, product launches, competitive analysis, technological advancements and various other factors that enhance sales of a firm or perhaps provide insights to focus on merger and acquisition as a strategy or enter into strategic agreements or joint ventures etc.
- The report contains company profiles of the top companies operating in the market along with their respective revenue and operating segments, geographical reach, market footprint, headquarters, growth rates, recent developments, product /services, expansion strategies, investments in expansion, and more.
Similar Research reports by Reports and Data of Pharma and Healthcare Industry:
Stem Cell Manufacturing Market Size, Share & Analysis, By Product (HSCs, MSCs, iPSCs, ESCs, Instruments, Media, Consumables), Application (Research, Target Identification, Therapy (Autologous, Allogeneic), Cell Banks), End User (Pharma, Hospitals) And By Region Forecast To 2028
Ultrasound Systems Market Size, Share & Analysis, By Technology (Diagnostic (2D, 3D, Doppler), Therapeutic (HIFU, ESWL)), By Device Display (Colour, B&W), Portability (Trolley, Compact, POC), By Application (Gynaecology, Urology, Cardiology, Orthopaedic), By End user (Hospitals, Surgical Centres, Diagnostic Centres, Others) and Region, Forecast To 2028
Cancer Pain Market Size, Share & Analysis, By Drug Type (Opioids, Non-steroidal Anti-inflammatory Drugs), By Route of Administration (Parenteral, Oral), By Application (Lung Cancer, Colorectal Cancer, Breast Cancer, Blood Cancer, Prostate Cancer), By End-Use (Hospitals, Specialty Clinics, Homecare), And By Region Forecasts To 2028
Deep Brain Stimulation Devices Market By Product Type (Single-Channel Deep Brain Stimulator, Dual-Channel Deep Brain Stimulator), By Application (Parkinson’s Disease, Epilepsy, Essential Tumors, and Others), By End-Use (Hospitals, Ambulatory Surgical Centers, and Others), and By Region
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors. For more information,
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Read Latest Press Release @ https://www.reportsanddata.com/press-release/global-nanomedicine-market